Glaucoma and Cataract Surgery Devices Market Size, Share, Growth and Industry Analysis, By Types (Glaucoma Surgery Device, Cataract Surgery Device), By Applications (Hospital, Ophthalmology Clinic, Outpatient Surgical Center), Regional Insights and Forecast to 2035
Buy Now - USD 4,900
Glaucoma and Cataract Surgery Devices Market Size
The Global Glaucoma and Cataract Surgery Devices Market was valued at USD 947.54 Million in 2025 and expanded to USD 1172.11 Million in 2026, further advancing to USD 1449.9 Million in 2027. The market is forecast to reach USD 7948.69 Million by 2035, registering a CAGR of 23.7% during the projected period from 2026 to 2035, supported by technological innovation, capacity expansion strategies, increasing capital investments, and rising demand across global end-use industries.
The US scissor lifts market is driven by increasing construction activities, infrastructure development, and a rising focus on worker safety. Growing demand for efficient, flexible aerial work platforms further fuels market expansion across industrial and commercial sectors.
The global glaucoma and cataract surgery devices market is experiencing significant growth, driven by the increasing prevalence of these eye conditions worldwide. As of 2022, the market was valued at approximately USD 8.5 billion and is projected to grow by 78% to reach around USD 15.2 billion by 2030. This expansion is attributed to factors such as the aging global population, advancements in surgical technologies, and a growing awareness of eye health. Notably, cataracts remain the leading cause of blindness globally, accounting for about 51% of cases, underscoring the critical need for effective surgical interventions.
Glaucoma and Cataract Surgery Devices Market Trends
Several key trends are shaping the glaucoma and cataract surgery devices market. The development of minimally invasive glaucoma surgery (MIGS) devices has revolutionized treatment approaches, with over 60% of new surgical procedures now utilizing these advanced techniques. These procedures offer smaller incisions and reduce trauma to the eye by 45%, leading to faster recovery times and improved patient outcomes. In 2023, phacoemulsification systems, which utilize ultrasound technology for cataract removal, held the largest market share, accounting for 42% of the global market. This dominance is due to their 95% efficiency rate and widespread adoption in surgical practices.
The aging population is another significant factor contributing to market growth. As the global demographic shifts towards an older average age, the incidence of age-related eye conditions like glaucoma and cataracts has risen by 30%, increasing the demand for surgical interventions. This demographic trend is expected to continue, further propelling the market.
Regionally, North America has maintained a substantial 55% share of the glaucoma surgery devices market, attributed to advanced healthcare infrastructure and a high prevalence of eye disorders. However, the Asia-Pacific region is anticipated to exhibit the fastest growth rate, with a projected 65% increase in market size over the coming years. This surge is driven by factors such as a rapidly aging population, increasing healthcare expenditure, and improving access to medical services.
Market Dynamics
The glaucoma and cataract surgery devices market is witnessing significant growth due to increasing incidences of eye-related disorders globally. Glaucoma and cataracts are among the leading causes of vision impairment and blindness, especially in aging populations. As the global geriatric population rises, the demand for advanced surgical devices tailored for glaucoma and cataract treatment surges. Technological advancements in minimally invasive surgical procedures, coupled with the increasing awareness about eye health, further fuel the market’s expansion. The market dynamics are shaped by evolving patient preferences, innovations in surgical tools, and the adoption of sophisticated medical devices aimed at improving surgical outcomes and patient recovery time. Additionally, increased investment in ophthalmology research and development, along with supportive government initiatives for vision care programs, is contributing to market expansion. The rising popularity of outpatient surgical procedures and the development of portable and user-friendly surgical devices are also reshaping the market landscape.
DRIVER
"Rising Prevalence of Eye Disorders"
The increasing incidence of glaucoma and cataracts worldwide is one of the primary drivers of market growth. According to the World Health Organization (WHO), approximately 4.5 million people globally are blind due to glaucoma, while cataracts account for more than 50% of global blindness cases. The growing elderly population, particularly in regions like North America, Europe, and parts of Asia-Pacific, is at higher risk of developing these conditions. In the United States alone, the number of people with cataracts is projected to reach 38.5 million by 2032. This rising patient pool creates a heightened demand for advanced surgical devices designed to offer effective and efficient treatment options, leading to market growth. Moreover, the increasing prevalence of lifestyle-related diseases such as diabetes, which is a risk factor for both glaucoma and cataracts, further amplifies the demand for surgical interventions. In addition, the growing emphasis on early diagnosis and regular eye check-ups is encouraging more patients to opt for surgical treatments, thereby boosting device adoption.
RESTRAINT
"High Cost of Advanced Surgical Devices"
Despite the promising growth, the high cost associated with glaucoma and cataract surgery devices poses a significant restraint on the market. Advanced surgical equipment like femtosecond lasers and intraocular lenses (IOLs) often come with steep price tags, making them inaccessible in lower-income regions. For instance, the average cost of femtosecond laser-assisted cataract surgery can range between $1,500 and $3,000 per eye in the United States, limiting the adoption rate among patients without comprehensive insurance coverage. Additionally, the financial burden on healthcare systems in developing nations often restricts the procurement of state-of-the-art surgical devices, further hindering market expansion. The high cost of maintenance and the need for specialized training to operate these advanced devices also contribute to limiting their widespread adoption. Moreover, disparities in healthcare infrastructure and the lack of reimbursement policies for advanced surgical procedures in several countries create additional barriers to market penetration.
OPPORTUNITY
"Technological Advancements in Surgical Devices"
The integration of advanced technologies in surgical devices presents substantial opportunities for market growth. Innovations such as micro-invasive glaucoma surgery (MIGS) devices and advanced intraocular lenses are enhancing surgical efficiency and patient outcomes. For example, MIGS devices have gained popularity due to their ability to reduce intraocular pressure with minimal complications and faster recovery times. Furthermore, the development of smart IOLs, equipped with sensors to monitor intraocular pressure post-surgery, offers promising potential in post-operative care. As technology continues to evolve, the adoption of such innovative devices is expected to drive significant growth in the glaucoma and cataract surgery devices market. The incorporation of artificial intelligence (AI) in surgical planning and robotics-assisted surgeries is also gaining traction, allowing for greater precision and reduced risk of complications. Additionally, collaborations between medical device companies and research institutions are fostering the development of next-generation devices, creating new growth avenues in the market.
CHALLENGE
"Limited Access to Advanced Surgical Care"
One of the major challenges facing the glaucoma and cataract surgery devices market is the limited access to advanced surgical care in developing and underdeveloped regions. Many countries in Africa, South America, and parts of Asia lack the necessary infrastructure and trained healthcare professionals to carry out advanced eye surgeries. According to the International Agency for the Prevention of Blindness (IAPB), over 90% of global blindness cases occur in low- and middle-income countries, where access to advanced surgical equipment remains scarce. Additionally, logistical challenges related to the distribution of high-end surgical devices further exacerbate the problem, preventing timely treatment for patients in remote areas.
Segmentation Analysis
The glaucoma and cataract surgery devices market can be segmented based on type and application, providing a clearer understanding of the specific areas driving growth and facing challenges.
By Type
-
Glaucoma Surgery Devices: Glaucoma surgery devices are designed to manage intraocular pressure and prevent optic nerve damage. Devices like micro-invasive glaucoma surgery (MIGS) implants and drainage devices are gaining traction due to their ability to offer effective pressure reduction with minimal invasiveness. According to the American Academy of Ophthalmology, MIGS procedures have increased by 152% over the past five years, demonstrating their growing popularity. These devices are particularly preferred for their shorter recovery times and reduced risk of post-surgical complications compared to traditional methods.
-
Cataract Surgery Devices: Cataract surgery devices include phacoemulsification systems, femtosecond lasers, and intraocular lenses (IOLs), which are critical for the successful removal of cloudy lenses and restoring vision. The demand for premium IOLs, such as toric and multifocal lenses, is rising due to their enhanced visual outcomes. The National Eye Institute estimates that more than 20 million cataract surgeries are performed globally each year, emphasizing the need for advanced and efficient surgical devices to meet this demand.
By Application
-
Hospitals: Hospitals represent a major end-user segment for glaucoma and cataract surgery devices, driven by the availability of advanced infrastructure and specialized ophthalmic departments. Large-scale hospitals often invest in high-end surgical equipment like femtosecond lasers and sophisticated imaging systems, ensuring better patient outcomes. In developed countries, over 60% of cataract surgeries are performed in hospital settings due to the comprehensive care they provide.
-
Ophthalmology Clinics: Ophthalmology clinics are gaining prominence due to their focused expertise and quicker patient turnaround times. These clinics often specialize in outpatient procedures and offer personalized care, making them a preferred choice for many patients. In the United States, over 40% of glaucoma surgeries are conducted in specialized eye clinics, reflecting their importance in market growth.
-
Outpatient Surgical Centers: Outpatient surgical centers (OSCs) are becoming increasingly popular due to their cost-effectiveness and efficiency. These centers are equipped with advanced surgical devices and offer same-day procedures, reducing hospital stays and overall treatment costs. According to the Ambulatory Surgery Center Association, OSCs perform nearly 25% of all cataract surgeries in the U.S., highlighting their growing role in the healthcare ecosystem.
Regional Outlook
The glaucoma and cataract surgery devices market is expected to witness robust growth across various regions due to rising incidences of eye disorders and advancements in surgical technologies. Increasing awareness regarding early diagnosis and treatment, along with improving healthcare infrastructure, is driving demand globally. The market is also propelled by the growing geriatric population and rising adoption of advanced ophthalmic devices. North America, Europe, Asia-Pacific, and the Middle East & Africa are key regions contributing to the market’s expansion, with each offering unique growth opportunities and facing distinct challenges.
North America
North America holds a significant share in the global glaucoma and cataract surgery devices market, driven by high healthcare expenditure and advanced medical infrastructure. The United States is a major contributor due to the increasing prevalence of glaucoma and cataracts among the aging population. According to the American Academy of Ophthalmology, over 3 million Americans suffer from glaucoma, and cataract surgery is one of the most commonly performed procedures in the country. Canada also contributes to market growth with its well-established healthcare system and rising adoption of innovative surgical devices. Strong presence of key market players and frequent technological advancements further bolster the regional market.
Europe
Europe is a prominent market for glaucoma and cataract surgery devices, supported by increasing healthcare investments and a rising aging population. Countries like Germany, the United Kingdom, and France lead the market with their advanced medical facilities and high adoption of cutting-edge ophthalmic technologies. According to Eurostat, around 20% of Europe’s population is aged 65 and older, a key demographic for glaucoma and cataract prevalence. The region’s focus on improving patient outcomes and government initiatives promoting eye health screenings drive market growth. Additionally, the presence of well-established medical device manufacturers enhances market competitiveness.
Asia-Pacific
Asia-Pacific is anticipated to witness the fastest growth in the glaucoma and cataract surgery devices market due to its large population base and increasing healthcare awareness. China and India are major contributors, driven by their rapidly expanding healthcare sectors and rising cases of eye disorders. According to the World Health Organization, cataracts account for nearly 50% of blindness cases in the region. Japan also plays a crucial role, with its advanced medical technologies and high rate of surgical procedures. Increasing disposable income and government initiatives aimed at reducing preventable blindness further support market growth in Asia-Pacific.
Middle East & Africa
The Middle East & Africa region shows promising potential for the glaucoma and cataract surgery devices market, despite challenges related to limited healthcare access in some areas. Countries like Saudi Arabia, the UAE, and South Africa are leading market contributors due to increasing investments in healthcare infrastructure and rising awareness of eye health. According to the International Agency for the Prevention of Blindness, cataracts remain the leading cause of blindness in the region. Efforts to enhance medical facilities and government programs promoting early diagnosis and treatment drive market expansion.
LIST OF KEY GLAUCOMA AND CATARACT SURGERY DEVICES MARKET COMPANIES PROFILED
- Alcon
- Johnson & Johnson
- Bausch & Lomb
- Topcon Corporation
- Lumenis
- Allergan
- Carl Zeiss Meditec
- Essilor International
- HAAG-Streit Holding
- Nidek
- Ziemer Ophthalmic Systems
- Ellex Medical Lasers
- Santen Pharmaceutical
- Abbott Laboratories
- Zabbys
- STAAR Surgical Company
- Hoya Corporation
- Aurolab
Top Companies with Highest Market Share
-
Alcon: 27% market share: Alcon’s dominance in the market is attributed to its extensive product portfolio and strong global presence. The company’s innovative surgical devices and consistent technological advancements have strengthened its position.
-
Johnson & Johnson: 22% market share: Johnson & Johnson’s strong market share is supported by its comprehensive range of ophthalmic products and strategic acquisitions. The company’s focus on research and development has driven its growth and market influence.
Investment Analysis and Opportunities
The glaucoma and cataract surgery devices market presents substantial investment opportunities driven by increasing demand for advanced ophthalmic solutions and a growing patient population. The global rise in aging demographics and the associated prevalence of vision disorders have led to a surge in surgical interventions, with cataracts and glaucoma being the leading causes of preventable blindness worldwide. According to the World Health Organization, over 1 billion people worldwide suffer from vision impairment that could have been prevented or treated, underscoring the urgent need for effective surgical devices and diagnostic tools. This creates a lucrative market for innovative surgical devices and diagnostic tools, with companies focusing on enhancing surgical precision, safety, and patient outcomes. Furthermore, government initiatives aimed at enhancing healthcare infrastructure, particularly in emerging economies, present new avenues for market expansion. These initiatives often include increased funding for ophthalmic care, subsidized surgical procedures, and efforts to improve access to advanced medical technologies. Strategic partnerships and collaborations between medical device companies and healthcare providers are also driving technological advancements and market penetration, fostering a competitive and innovation-driven environment.
New Products Development
The glaucoma and cataract surgery devices market has witnessed significant innovation with the introduction of new products designed to improve surgical precision and patient outcomes. In 2023 and 2024, several companies launched advanced intraocular lenses (IOLs) and minimally invasive glaucoma surgery (MIGS) devices, revolutionizing the standard of care in ophthalmology. For instance, Alcon introduced a next-generation multifocal IOL, offering enhanced visual outcomes across varying distances, reducing the need for glasses post-surgery, and improving patient satisfaction. Johnson & Johnson unveiled a novel MIGS device aimed at reducing intraocular pressure more effectively, providing a safer and less invasive alternative to traditional glaucoma surgeries. These product launches reflect the industry’s focus on innovation and the growing adoption of advanced technologies, including smart implants and biocompatible materials that enhance device longevity and performance. Additionally, the development of laser-assisted surgical devices and AI-driven diagnostic tools continues to shape the market’s future, with AI algorithms enabling early disease detection, personalized treatment plans, and enhanced surgical planning, thereby improving overall clinical outcomes.
Recent Developments by Manufacturers in Glaucoma and Cataract Surgery Devices Market
- Alcon launched its advanced Vivity IOL in early 2023, providing extended depth of focus for cataract patients and addressing common post-surgery visual disturbances such as glare and halos.
- Johnson & Johnson acquired a leading ophthalmic startup in mid-2023, expanding its portfolio of innovative eye care solutions and strengthening its position in the rapidly evolving ophthalmic market.
- Carl Zeiss Meditec introduced a state-of-the-art femtosecond laser system for precise cataract surgeries in late 2023, enhancing surgical accuracy, reducing recovery times, and minimizing the risk of complications.
- Bausch & Lomb partnered with a research institute in 2024 to develop AI-powered diagnostic tools for glaucoma detection, enabling earlier diagnosis and more effective disease management through advanced data analysis and predictive modeling.
- Topcon Corporation launched a new non-contact tonometer in early 2024, enhancing patient comfort and diagnostic accuracy by providing quick, painless intraocular pressure measurements crucial for glaucoma screening and monitoring.
Report Coverage
The report on the glaucoma and cataract surgery devices market provides a comprehensive analysis of market dynamics, including key drivers, challenges, and opportunities. It covers market segmentation by product type, end-user, and region, offering detailed insights into growth trends and demand patterns across various geographies and patient demographics. The report highlights the competitive landscape, profiling major players and their strategic initiatives, such as mergers and acquisitions, product launches, and collaborations aimed at enhancing market presence and technological capabilities. Additionally, it includes an analysis of technological advancements, regulatory frameworks, and investment trends shaping the market’s future, with a focus on the impact of evolving healthcare policies and reimbursement structures. With data sourced from reputable organizations and industry experts, the report offers valuable information for stakeholders looking to make informed decisions and capitalize on emerging market opportunities, ensuring a comprehensive understanding of market dynamics and future growth potential.
Glaucoma and Cataract Surgery Devices Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 947.54 Million in 2026 |
|
|
Market Size Value By |
USD 7948.69 Million by 2035 |
|
|
Growth Rate |
CAGR of 23.7% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation 
Download FREE Sample
|
||
Frequently Asked Questions
-
What value is the Glaucoma and Cataract Surgery Devices Market expected to touch by 2035?
The global Glaucoma and Cataract Surgery Devices Market is expected to reach USD 7948.69 Million by 2035.
-
What CAGR is the Glaucoma and Cataract Surgery Devices Market expected to exhibit by 2035?
The Glaucoma and Cataract Surgery Devices Market is expected to exhibit a CAGR of 23.7% by 2035.
-
Who are the top players in the Glaucoma and Cataract Surgery Devices Market?
Alcon, Johnson & Johnson, Bausch & Lomb, Topcon Corporation, Lumenis, Allergan, Carl Zeiss Meditec, Essilor International, HAAG-Streit Holding, Nidek, Ziemer Ophthalmic Systems, Ellex Medical Lasers, Santen Pharmaceutical, Abbott Laboratories, Zabbys, STAAR Surgical Company, Hoya Corporation, Aurolab.
-
What was the value of the Glaucoma and Cataract Surgery Devices Market in 2025?
In 2025, the Glaucoma and Cataract Surgery Devices Market value stood at USD 947.54 Million.
Our Clients
Trusted & Certified
